Analysts expect Quantum Biopharma Ltd. to report revenue of 2.02 M for Q1 25, against a range of 1.94 M to 2.10 M. The most recent reported quarter, Q4 25, came in at 0.00.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | 0.00 | 0.00 | 0.00 | - | - | - | - |
| High Estimate | 2.10 M | 3.24 M | 996,988.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Low Estimate | 1.94 M | 2.73 M | 849,320.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 2.02 M | 2.98 M | 923,154.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect Quantum Biopharma Ltd. to report earnings per share of -0.48 for Q3 26, against a range of -0.53 to -0.43. The most recent reported quarter, Q2 26, came in at -0.46, a 7.0% miss against the -0.43 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -2.88 | -2.78 | -3.42 | -3.27 | -1.26 | -0.19 | -3.00 | -0.46 | - | - |
| High Estimate | -2.53 | -0.68 | -0.63 | -0.17 | -2.34 | -0.93 | -0.44 | -0.41 | -0.43 | -0.67 |
| Low Estimate | -2.81 | -0.80 | -0.69 | -0.19 | -2.86 | -0.99 | -0.48 | -0.45 | -0.53 | -0.77 |
| Consensus Estimate | -2.67 | -0.74 | -0.66 | -0.18 | -2.60 | -0.96 | -0.46 | -0.43 | -0.48 | -0.72 |